SCHEMBL7300722

SCHEMBL7300722

O=c1[nH]c(=O)n(CCCCN2CC=C(c3ccccc3)CC2)c2cccc(O)c12

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 12/20 0.79
HTR7 P34969 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12231980 0.88 PARP1 (1.00) PARP1
SCHEMBL7307887 0.88 PARP1 (0.79) PARP1HTR7
SCHEMBL7309614 0.88 PARP1 (0.79) PARP1HTR7
SCHEMBL7302722 0.88 PARP1 (0.79) PARP1
Hydrochloric Acid SCHEMBL7301292 0.87 PARP1 (0.98) PARP1
SCHEMBL7302586 0.85 PARP1 (0.75) PARP1HTR7
SCHEMBL7299268 0.85 PARP1 (0.73) PARP1
SCHEMBL7305161 0.84 PARP1 (0.73) PARP1
SCHEMBL7303316 0.84 PARP1 (0.64) PARP1
Sulfuric Acid SCHEMBL7308620 0.84 PARP1 (0.71) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US claimed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP claimed
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed